Company Data

NuCana plc

Ticker
NCNA
Current Price
$1.06 10.42%
Market Cap
$2.4M
Price Target
Refer to Report
Volume
69.5K
52wk Range
$0.85 - $19.41
Advanced Market Data

Overview

NuCana PLC is a biopharmaceutical company focused on improving treatment outcome for cancer patients by ProTide technology. Utilising proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. Geographically operates through the region of the United States.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy